treatment efficacy. 3, 4 There is neither standardized prophylactic nor therapeutic strategies available proven to mitigate the radiation enteritis (RE) symptoms or allow safe radiation dose escalation for better cancer control. In 2002, Pietro Delia 5 reported that use of Lactobacillus rhamnosus could prevent the occurrence of diarrhoea in patients receiving radiotherapy. Later, Crawford and Gordon 6 revealed that germ-free mice were markedly resistant to lethal RE. And after faecal microbiota transplantation, the intestinal function and survival rate were significantly improved in irradiated mice. 7 These reports suggest a human-microbiome link upon irradiation and provided an insight into potential radio-protective therapeutics.
The advancement of recent next-generation sequencing technologies and bioinformatics has changed the way research is done in microbial ecology. It analyses the complete bacterial genome sequences and provides enormous amounts of information. 8 Direct evidence of alterations in the overall composition of the gastrointestinal microbiome has been reported in various studies. Dinakaran et al 9 identified different patterns of colon microbiome between
Caucasians and African-Americans. They also found that the proportion of bacteria in the inflammatory bowel disease samples was altered compared to adjacent healthy samples. Lavelle et al 10 demonstrated spatial variation between the luminal and mucosal microbiome in ulcerative colitis and healthy controls. In addition, Nan et al 11 revealed 75 245 genes differing between liver cirrhosis patients and healthy individuals, and most of the patient-enriched species were of buccal origin, suggesting an invasion of the gut from the mouth.
In this study, using the high-throughput 16S rRNA gene sequencing, we identified specific faecal microbial signatures in patients with RE and sought to elucidate potential biomarkers or mechanistic principles how the gut microbiota dysbiosis may impact the pathogenesis of RE. The results will also provide useful information about the therapeutic value of microecological preparation for RE.
| MATERIAL S AND ME THODS

| Sample collection
Eighteen patients with stage II-IV cervical cancer (CCa) who had not received any treatments for those conditions and were undergoing pelvic radiotherapy were recruited in our department from June 2015
to January 2016. The detailed clinical parameters are shown in Table 1 .
The exclusion criteria were as follows: recent (<2 months prior) use of any antibiotic or probiotic therapy, recent (<2 weeks prior) use of any proton pump inhibitors, known any other enteritis, 9,10 known autoimmune condition, significant gastrointestinal disorder, age <18 years, vegetarians, abnormal BMI value (<18.5 or >24), known history of any other cancer, 12 and significant liver, renal, or peptic ulcer disease.
Baselines of bowel habit and symptom were recorded, and patients with prior higher bowel symptoms were excluded as well. Pelvic radiotherapy was delivered at total doses of 50. (515F) and 5'-GGACTACHVGGGTWTCTAAT-3' (806R). The amplified products were purified with Qiagen Gel Extraction Kit. Sequencing was performed using a 250-bp paired-end sequencing protocol on an Illumina HiSeq2500 platform.
| In vitro studies
The human normal colonic epithelial cell line consisting of FHC (foetal colon) was provided by Dr Liang Peng (The First Affiliated
Hospital of Guangzhou Medical University), and cultured routinely in RPMI1640 medium. Faecal bacterial suspension was obtained as previously described. 13 
| Bioinformatics and statistical analysis
Paired-end reads were assigned to samples based on their unique barcode and bioinformatic processing was done as previously described. 15, 16 Briefly, quality control was performed using QIIME V1.7.0 software package to obtain high-quality clean tags. For in vitro studies, data from three or more independent experiments was expressed as mean ± SE and processed using SPSS18.0 statistical software. Statistical analysis was performed with t test, non-parametric Mann-Whitney and factorial analysis. P < 0.05 from two-sided tests was taken as statistical significance.
| RE SULTS
In total, we generated 1 617 140 paired-end reads of high-quality sequences (average 57 755 per sample). The total number of OTUs Then we compared the differences in taxonomic abundances between individuals with and without RE at various levels. At the phylum level, Bacteroidetes was the most predominant gut microbiota, contributing 38.59% and 54.12% in RE group and in non-RE group respectively, followed by Proteobacteria (37.10% and 15.97%) and To identify the specific bacterial taxa associated with RE, we compared the composition of faecal microbiota using linear discriminant analysis effect size (LEfSe). It revealed 79 discriminative features (LDA score > 4, Figure 3A ,
B). Members of Bacteroides, Bacteroidaceae
and Plebeius were enriched in non-REs, whereas Megamonas, Novosphingobium and Prevotella were enriched in RE samples. The latter three could thus be used as biomarkers to identify RE patients.
A cladogram represented the structure of faecal microbiota and the predominant bacteria was shown in Figure 3C . It provided the relationship between taxa at different taxonomic levels. For example, Desulfovibrionaceae (family) was under Desulfovibrionales (order)
which was under Deltaproteobacteris (class).
We also investigated microbial differences between faecal samples analysis further revealed two discriminative features (LDA score > 4, Figure 4E -lower); members of Coprococcus and Desulfovibrio were enriched in the pre-RT samples. Therefore they might be used as biomarkers to identify patients most likely to develop RE.
Patient samples were further classified into three groups according to the grade of RE using the Radiation Therapy Oncology Group (RTOG) grading system. 19 Three patients in the RE group developed grade 1 radiation toxicity (RE1), three developed grade 2 toxicity (RE2) and another four developed grade 3 toxicity (RE3). No grade 4 or 5 was recorded. Relative to those with mild toxicity, patients with severe enteritis had a significantly reduced α-diversity (ρ = 0.034, Figure 5A ) but a non-significantly increased β-diversity ( Figure 5B ).
Patients at grade 3 RE had lowest α-diversity and highest β-diversity among all the RE patients, indicating a potential trend of gradual microbial response to radiation inflammation. Analysis of microbial composition revealed a grade-related microbial feature ( Figure 5C ).
Proportionally, six bacterial taxa were enriched in RE1, and two in RE3. Metastat analysis showed that among the mild-grade RE-enriched genus, three were significantly more abundant in RE1 patients, including Virgibacillus (ρ = 0.008), Alcanivorax (ρ = 0.010) and Phenybacterium (ρ = 0.038); three were more abundant in RE2 patients, including Coprococcus (ρ = 0.044), Collinsella (ρ = 0.022), and rc4_4 (ρ = 0.020) ( Figure 5D ).
An epithelial monolayer cell co-culture model was used to explore the effects of radiation-induced microbial dysbiosis on epithelial inflammatory response. Following co-culture with bacterial suspensions from RE3 patients, compared with suspension from non-RE patients, inflammatory and barrier markers were significantly downregulated. Membrane Syndecan-1 was released from the cell surface.
Tight junction protein ZO-1 and occludin were decreased. P65, a canonical component of NF-κB pathway, was phosphorylated as well ( Figure 6A ). RE-derived microbiota also stimulated remarkable TNF-α and IL-1β secretion (ρ = 0.001 and 0.002, Figure 6B ). Transepithelial electrical resistance was decreased consistently and significantly in a time-dependent manner through cells co-incubated with RE3-derived microbiota (ρ < 0.05, Figure 6C ). Consistent with the higher TEER drop, higher FITC-dextran permeation was also observed (ρ = 0.007, Figure 6D ). Furthermore, soluble Syndecan-1, as well as cytokines TNF-α and IL-1β in the serum of RE patients were all significantly higher than in patients without RE (ρ < 0.001, Figure 6E , F).
| D ISCUSS I ON
Since its first report in 1897, 20 Several previous studies have indicated that patients receiving radiotherapy exhibit marked changes in gut microbiota, some of which were specific to particular patients. For example, the Firmicutes/ Bacteroidetes ratio was markedly altered prior to radiotherapy in patients who later developed diarrhoea. 21 Patients with acute postradiotherapy diarrhoea had profound increase in Actinobacteria and Bacilli, and decrease in Clostridia. 22 In our study, unique microbial signatures were observed at the tested grades and phases of shedding of mucosa, disruption of barrier and initiation of coagulation cascade. 23 For example, pathway analysis on the gene expression profiles has identified radiation-induced time-, dose-and even segment-dependent up-regulation of TNF-α, claudin-2, MMP7 and EDA2R. 24 Radiation also provokes increase in MPO activity and CXC chemokine levels. 25 Activation of these pathways suggest that colon sustains severe mucosal inflammation and barrier disruption, and might influence and disturb the balance of microecology. We previously demonstrated that loss of Syndecan-1 in the inflamed intestine impaired normal intestinal barrier and led to bacterial translocation through mucosa. 14 Winter et al 26, 27 found that host-derived nitrate in response to mucosal inflammation conferred a growth advantage to commensal Escherichia coli or pathogenic Salmonella enterica in the mice intestine. Taken together, although it is tricky to decipher the question of cause and effect, these data are still sufficient to confirm that the unique radiation-induced dysbiosis is closely associated with inflammatory response.
Our results suggested that the pre-existing changes in gut microbial ecology may serve as a predictive marker to identify patients who are more likely to progress to RE during pelvic irradiation, in agreement with Wang et al's proposal. 21 Moreover, our data suggested possibility to prevent or treat RE by targeting the gut microbiota. In mouse model, gavage of Lactobacillus rhamnosus GG before radiation repositioned COX-2 expression through TLR-2/MyD88 signalling and reduced epithelial apoptosis and crypt loss from radiation injury. 28 In patients, prevention of radiotherapy-induced mucositis by probiotics has been investigated in several clinical trials. 29, 30 Although the results were inconsistent, and strong evidence is lacking, there was still some promising data. Chitapanarux's ran- induce detrimental effects in these individuals; note some published reports of septic complications because of probiotics. 34 Therefore, safety concerns about the use of probiotics should also be carefully investigated.
In conclusion, we reported the comprehensive analysis of gut microbiota in patients with RE using faecal samples by high-throughput 16S rRNA sequencing. We identified the radiation-induced impaired gut microbiota and its relationship with RE. Our results will be helpful for the prediction and treatment of cancer patients receiving pelvic irradiation and suffering from RE. Furthermore, multicenter, randomized and placebo-controlled trials are needed to confirm this.
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